WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004096214) A RAPIDLY DISINTEGRABLE COMPOSITION FOR MASKING THE BITTER TASTE OF ONDANSETRON OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/096214    International Application No.:    PCT/KR2004/000230
Publication Date: 11.11.2004 International Filing Date: 06.02.2004
Chapter 2 Demand Filed:    26.11.2004    
IPC:
A61K 31/4178 (2006.01)
Applicants: YUHAN CORPORATION [KR/KR]; 49-6 Taebang-dong, Tongjak-gu, Seoul 156-754 (KR) (For All Designated States Except US).
PARK, Young-Joon [KR/KR]; (KR) (For US Only).
KANG, Dae-Sik [KR/KR]; (KR) (For US Only)
Inventors: PARK, Young-Joon; (KR).
KANG, Dae-Sik; (KR)
Agent: LEE, Young-Pil; The Cheonghwa Building 1571-18, Seocho-dong, Seocho-gu, Seoul 137-874 (KR)
Priority Data:
10-2003-0026723 28.04.2003 KR
Title (EN) A RAPIDLY DISINTEGRABLE COMPOSITION FOR MASKING THE BITTER TASTE OF ONDANSETRON OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
(FR) COMPOSITION SE DESINTEGRANT RAPIDEMENT QUI MASQUE LE GOUT AMER DE L'ONDANSETRON OU D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CE DERNIER
Abstract: front page image
(EN)The present invention provides a composition for oral administration, which disintegrates in the oral cavitywithin about 60 seconds and masks a bitter taste of ondansetron or a pharmaceutically acceptable salt thereof, the composition comprising a therapeutically effective amount of ondansetron or a pharmaceuticallyacceptable salt thereof and an alkalizing agent.
(FR)La présente invention concerne une composition destinée à l'administration par voie orale qui se désintègre dans la cavité orale en environ 60 secondes et qui masque le goût amer de l'ondansétron ou d'un sel pharmaceutiquement acceptable de ce dernier, la composition comprenant une quantité thérapeutiquement efficace d'ondansétron ou d'un sel pharmaceutiquement acceptable de ce dernier et un agent alcalifiant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)